» Articles » PMID: 24593040

Phenotyping Community-acquired Pneumonia According to the Presence of Acute Respiratory Failure and Severe Sepsis

Abstract

Background: Acute respiratory failure (ARF) and severe sepsis (SS) are possible complications in patients with community-acquired pneumonia (CAP). The aim of the study was to evaluate prevalence, characteristics, risk factors and impact on mortality of hospitalized patients with CAP according to the presence of ARF and SS on admission.

Methods: This was a multicenter, observational, prospective study of consecutive CAP patients admitted to three hospitals in Italy, Spain, and Scotland between 2008 and 2010. Three groups of patients were identified: those with neither ARF nor SS (Group A), those with only ARF (Group B) and those with both ARF and SS (Group C) on admission.

Results: Among the 2,145 patients enrolled, 45% belonged to Group A, 36% to Group B and 20% to Group C. Patients in Group C were more severe than patients in Group B. Isolated ARF was correlated with age (p < 0.001), COPD (p < 0.001) and multilobar infiltrates (p < 0.001). The contemporary occurrence of ARF and SS was associated with age (p = 0.002), residency in nursing home (p = 0.007), COPD (p < 0.001), multilobar involvement (p < 0.001) and renal disease (p < 0.001). 4.2% of patients in Group A died, 9.3% in Group B and 26% in Group C, p < 0.001. After adjustment, the presence of only ARF had an OR for in-hospital mortality of 1.85 (p = 0.011) and the presence of both ARF and SS had an OR of 6.32 (p < 0.001).

Conclusions: The identification of ARF and SS on hospital admission can help physicians in classifying CAP patients into three different clinical phenotypes.

Citing Articles

Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia.

Lin Y, Li Y, Cui X, Zhu N, Li X J Inflamm Res. 2025; 17():11829-11843.

PMID: 39802154 PMC: 11725244. DOI: 10.2147/JIR.S499326.


Derivation and validation of generalized sepsis-induced acute respiratory failure phenotypes among critically ill patients: a retrospective study.

Choudhary T, Upadhyaya P, Davis C, Yang P, Tallowin S, Lisboa F Crit Care. 2024; 28(1):321.

PMID: 39354616 PMC: 11445942. DOI: 10.1186/s13054-024-05061-4.


Machine learning-based derivation and validation of three immune phenotypes for risk stratification and prognosis in community-acquired pneumonia: a retrospective cohort study.

Qin Q, Yu H, Zhao J, Xu X, Li Q, Gu W Front Immunol. 2024; 15:1441838.

PMID: 39114653 PMC: 11303239. DOI: 10.3389/fimmu.2024.1441838.


Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study.

Meyer H, Modl L, Unruh O, Xiang W, Berger S, Muller-Plathe M Infection. 2024; 52(6):2359-2370.

PMID: 38761325 PMC: 11621138. DOI: 10.1007/s15010-024-02292-z.


Derivation and Validation of Generalized Sepsis-induced Acute Respiratory Failure Phenotypes Among Critically Ill Patients: A Retrospective Study.

Choudhary T, Upadhyaya P, Davis C, Yang P, Tallowin S, Lisboa F Res Sq. 2024; .

PMID: 38746442 PMC: 11092838. DOI: 10.21203/rs.3.rs-4307475/v1.


References
1.
Barlow G, Nathwani D, Myers E, Sullivan F, Stevens N, Duffy R . Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia. J Antimicrob Chemother. 2007; 61(2):442-51. DOI: 10.1093/jac/dkm462. View

2.
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell G, Dean N . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27-72. PMC: 7107997. DOI: 10.1086/511159. View

3.
Bordon J, Aliberti S, Duvvuri P, Wiemken T, Peyrani P, Natividad I . Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes. Int J Infect Dis. 2013; 17(5):e293-8. DOI: 10.1016/j.ijid.2012.09.021. View

4.
Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M . Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011; 17 Suppl 6:E1-59. PMC: 7128977. DOI: 10.1111/j.1469-0691.2011.03672.x. View

5.
Dellinger R, Levy M, Rhodes A, Annane D, Gerlach H, Opal S . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2):165-228. PMC: 7095153. DOI: 10.1007/s00134-012-2769-8. View